2019 (v1)
Journal article
International audience
Uploaded on: December 4, 2022
-
-
2012 (v1)Journal article
National audience
Uploaded on: December 4, 2022 -
2012 (v1)Journal article
National audience
Uploaded on: December 4, 2022 -
March 2017 (v1)Journal article
60-70% of AML patients have an indication of allogeneic hematopoietic stem cell transplantation (allo-HSCT) during their treatment. Graft versus host disease (GvHD), the major cause of mortality and comorbidities post-transplantation, develops by immunological mechanism and decides greatly prognosis and quality of life (QoL) of graft recipient....
Uploaded on: February 28, 2023 -
2020 (v1)Journal article
In this study, we aimed to refine prognostication of older with acute myeloid leukemia (AML) after intensive chemotherapy. Five hundred and nine patients aged 60 years or older (median age, 68 years) were prospectively enrolled in the intensive Acute Leukemia French Association (ALFA)-1200 trial between 2012 and 2016, and 471 patient samples...
Uploaded on: December 4, 2022 -
November 15, 2022 (v1)Journal article
No description
Uploaded on: March 25, 2023